Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?
Shenmiao Yang1, Neil E Kay2, Min Shi3
1Peking University Peoples Hospital, Peking University Institute of Hematology, Beijing, China.
Leukemia
|September 28, 2021
Abstract
No abstract available in PubMed .
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.2K
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.7K
